Literature DB >> 21941145

Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group.

Conrad V Fernandez1, Ning Li, Elizabeth A Mullen, Paul E Grundy, Elizabeth J Perman, Robert C Shamberger, Peter F Ehrlich, Jeffrey S Dome.   

Abstract

Very low risk Wilms tumor is defined by favorable histology, age below 2 years, tumor weight less than 550 g, and stage I. The Children's Oncology Group is currently studying a nephrectomy-only strategy for these patients but the accrual rate is slightly below expected. Twenty-five of 31 institutions responded with reasons by physicians and/or parents for electing not to participate. Parents were primarily concerned with the experimental nature of the study, whereas physicians were concerned about accurate staging, with some overlap. We point out the necessity of assessing these concerns in predicting feasibility of and accrual to a therapy reduction study.

Entities:  

Mesh:

Year:  2011        PMID: 21941145      PMCID: PMC3496383          DOI: 10.1097/MPH.0b013e31821b8dd5

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  14 in total

1.  Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.

Authors:  K Pritchard-Jones; A Kelsey; G Vujanic; J Imeson; C Hutton; C Mitchell
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 44.544

2.  Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH.

Authors:  R Ludwig; A Weirich; U Abel; W Hofmann; N Graf; M F Tournade
Journal:  Med Pediatr Oncol       Date:  1999-11

3.  Parental traumatic stress during and after paediatric cancer treatment.

Authors:  Annika Lindahl Norberg; Frank Lindblad; Krister K Boman
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

4.  Surgery only for the treatment of patients with stage I (Cassady) Wilms' tumor.

Authors:  E Larsen; A Perez-Atayde; D M Green; A Retik; L A Clavell; S E Sallan
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

5.  Anxiety and cancer-related worry of cancer patients at routine follow-up visits.

Authors:  C Lampic; A Wennberg; J E Schill; O Brodin; B Glimelius; P O Sjödén
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

6.  Radiation doses and risks in chest computed tomography examinations.

Authors:  Walter Huda
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

7.  Dose reduction and compliance with pediatric CT protocols adapted to patient size, clinical indication, and number of prior studies.

Authors:  Sarabjeet Singh; Mannudeep K Kalra; Michael A Moore; Randheer Shailam; Bob Liu; Thomas L Toth; Ellen Grant; Sjirk J Westra
Journal:  Radiology       Date:  2009-05-12       Impact factor: 11.105

Review 8.  Radiation risks from imaging studies in children with cancer.

Authors:  Elizabeth Robbins
Journal:  Pediatr Blood Cancer       Date:  2008-10       Impact factor: 3.167

9.  Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group.

Authors:  C M Owens; P A Veys; J Pritchard; G Levitt; J Imeson; C Dicks-Mireaux
Journal:  J Clin Oncol       Date:  2002-06-15       Impact factor: 44.544

10.  Disease-related distress in parents of children with cancer at various stages after the time of diagnosis.

Authors:  Krister Boman; Annika Lindahl; Olle Björk
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

View more
  5 in total

1.  Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.

Authors:  Conrad V Fernandez; Elizabeth J Perlman; Elizabeth A Mullen; Yueh-Yun Chi; Thomas E Hamilton; Kenneth W Gow; Fernando A Ferrer; Douglas C Barnhart; Peter F Ehrlich; Geetika Khanna; John A Kalapurakal; Tina Bocking; Vicky Huff; Jing Tian; James I Geller; Paul E Grundy; James R Anderson; Jeffrey S Dome; Robert C Shamberger
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

2.  Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement.

Authors:  Fernando A Ferrer; Katherine W Herbst; Conrad V Fernandez; Geetika Khanna; Jeffrey S Dome; Arlene Naranjo; Elizabeth A Mullen; James I Geller; Eric J Gratias; Robert Shamberger; Michael Ritchey; Peter F Ehrlich
Journal:  J Pediatr Urol       Date:  2014-03-15       Impact factor: 1.830

Review 3.  Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.

Authors:  Jeffrey S Dome; Elizabeth A Mullen; David B Dix; Eric J Gratias; Peter F Ehrlich; Najat C Daw; James I Geller; Murali Chintagumpala; Geetika Khanna; John A Kalapurakal; Lindsay A Renfro; Elizabeth J Perlman; Paul E Grundy; Conrad V Fernandez
Journal:  J Natl Compr Canc Netw       Date:  2021-08-01       Impact factor: 11.908

4.  A 10-Year Study of the Outcome of Wilms' Tumor in Central India and Identifying Practice Gaps.

Authors:  Vikesh Agrawal; Arpan Mishra; Sanjay Kumar Yadav; Dhananjaya Sharma; Himanshu Acharya; Aradhna Mishra; Rekha Agrawal; Roshan Chanchlani
Journal:  J Indian Assoc Pediatr Surg       Date:  2022-01-11

5.  Developing a survey of barriers and facilitators to recruitment in randomized controlled trials.

Authors:  Geetinder Kaur; Rosalind L Smyth; Paula Williamson
Journal:  Trials       Date:  2012-11-21       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.